Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to $3.4 million.

  • cbdMD's Cash & Equivalents rose 7195.74% to $3.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 million, marking a year-over-year increase of 7195.74%. This contributed to the annual value of $2.3 million for FY2025, which is 780.05% down from last year.
  • cbdMD's Cash & Equivalents amounted to $3.4 million in Q4 2025, which was up 7195.74% from $2.3 million recorded in Q3 2025.
  • In the past 5 years, cbdMD's Cash & Equivalents ranged from a high of $26.4 million in Q3 2021 and a low of $1.1 million during Q2 2025
  • For the 5-year period, cbdMD's Cash & Equivalents averaged around $7.4 million, with its median value being $2.6 million (2023).
  • Per our database at Business Quant, cbdMD's Cash & Equivalents skyrocketed by 7815.89% in 2021 and then plummeted by 8711.43% in 2023.
  • cbdMD's Cash & Equivalents (Quarter) stood at $19.7 million in 2021, then tumbled by 82.98% to $3.4 million in 2022, then plummeted by 55.11% to $1.5 million in 2023, then surged by 30.92% to $2.0 million in 2024, then surged by 71.96% to $3.4 million in 2025.
  • Its Cash & Equivalents was $3.4 million in Q4 2025, compared to $2.3 million in Q3 2025 and $1.1 million in Q2 2025.